More interestingly, we showed a positive linear correlation between the serum IL-21 levels and the VAS for arthritis or the DAS-28-ESR, and SSc patients with moderate–high joint involvement had statistically significantly higher serum IL-21 levels than SSc patients with a DAS28-ESR ≤ 3.2. Here, IL21 is linked to systemic sclerosis.